Predictive Role of FDG PET‐CT in Localised Rectal Carcinoma: A Systematic Review and Meta‐Analysis
- 17 February 2025
- journal article
- review article
- Published by Wiley in Journal of Medical Imaging and Radiation Oncology
- Vol. 69 (3) , 352-372
Abstract
Introduction: Rectal carcinoma (RC) has high incidence and rate of recurrence. Currently, routine 18‐ fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET‐CT) is not recommend for routine monitoring for post RC treatment. We examined the utility of FDG PET‐CT for the prognostication of patients with RC and what FDG PET‐CT metrics are of value.Methods: PubMed, Embase, MEDLINE, and Cochrane (Central) were comprehensively searched till 19 May 2024. A modified Newcastle Ottawa scale was used to assess for study bias. We presented our systematic review alongside pooled hazard ratios (HR) for maximum standardised uptake values (SUV) as a predictor of disease‐free survival (DFS) and overall survival (OS).Results: Eleven papers including 771 patients were included in our systematic review. Considering the current evidence, there is potential to consider percentage change in SUVmax, TLG, MTV, and lymph node highest peak SUV as possible predictors of outcome for localised non metastatic rectal carcinoma.Conclusions: Pooled meta‐analysis of three homogenous parameters examines the relationship of SUVMax and survival, and did not demonstrate correlation with survival outcomes. The overall pooled hazard ratio for pretreatment SUVMax to DFS was 0.69, CI (0.29–1.63). The overall pooled HR for post treatment SUVMax to DFS was 0.88, CI (0.43–1.81), and posttreatment SUVMax to OS was 1.73, CI (0.34–8.66). Post treatment FDG PET‐CT may have a role to play in the prognostic evaluation of RC patients; however, further data is required.Keywords
This publication has 32 references indexed in Scilit:
- A pilot study investigating the role of 18F‐FDG‐PET in the early identification of chemoradiotherapy response in anal cancerJournal of Medical Radiation Sciences, 2022
- Role of 18F-PET-CT to predict pathological response after neoadjuvant treatment of rectal cancerDiscover Oncology, 2021
- Interim Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography to Predict Pathologic Response to Preoperative Chemoradiotherapy and Prognosis in Patients With Locally Advanced Rectal CancerClinical Colorectal Cancer, 2016
- Early post-treatment FDG PET predicts survival after 90Y microsphere radioembolization in liver-dominant metastatic colorectal cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2014
- 18F-FDG PET/CT-based treatment response evaluation in locally advanced rectal cancer: a prospective validation of long-term outcomesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2013
- Early FDG PET response assessment of preoperative radiochemotherapy in locally advanced rectal cancer: correlation with long-term outcomeEuropean Journal of Nuclear Medicine and Molecular Imaging, 2012
- Role of PET/CT in the detection of liver metastases from colorectal cancerLa radiologia medica, 2009
- 2‐Fluoro‐2‐deoxy‐D‐glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinomaCancer, 2004
- Does Positron Emission Tomography Change Management in Primary Rectal Cancer? A Prospective AssessmentDiseases of the Colon & Rectum, 2004
- Preoperative Radiation with Concurrent 5-Fluorouracil for Locally Advanced T4-Primary Rectal CancerStrahlentherapie und Onkologie, 2000